Printer Friendly
The Free Library
6,672,335 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Antineoplastic agents topic

Subtopics (53)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
SCIENTISTS FIND A CURE FOR CANCER; Irish researchers claim new drug kills leukaemia cells. Nov 3, 2009 345
Over 65? Why some doctors think giving you the latest cancer drugs is just a waste. Nov 3, 2009 1251
ZEVALIN[R] Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology. Nov 3, 2009 859
SAREUM, the specialist cancer drug [...]; MARKET REPORT. Nov 3, 2009 74
Found, a drug that can kill leukaemia. Nov 3, 2009 394
Trinity team find the key to unlock leukaemia. Nov 3, 2009 266
The drug that can kill leukaemia. Nov 3, 2009 440
Found, the drug that can kill leukaemia. Nov 3, 2009 172
Marine sponges may harbour cancer cure. Nov 3, 2009 301
New drug 'can kill leukaemia'. Nov 3, 2009 227
Drug may buy vital time for early babies; Research aims to delay the onset of labour. Nov 2, 2009 620
Drug may halt early labour. Nov 2, 2009 299
Spain : Zeltia gets EU approval for ovarian cancer drug. Nov 2, 2009 50
Nano vehicle for cancer drugs ' works'. Nov 2, 2009 211
Cancer therapy center. Nov 1, 2009 106
France : Sanofi, Micromet seal early-stage cancer drug deal. Oct 29, 2009 126
Japan : Astellas, U.S. firm to develop, commercialize prostate cancer drug. Oct 29, 2009 122
United States : Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS. Oct 29, 2009 470
Healthy dose of exercise is good for lymphoma patients. Oct 28, 2009 368
Glaxo lifted after US approves drug; NEWS IN BRIEF. Oct 27, 2009 83
Endocyte Awarded Patent for Vitamin Receptor Binding Drug Delivery Conjugates. Oct 27, 2009 608
Obesity and leukemia relapses. Seppa, Nathan Brief article Oct 24, 2009 111
-- ZIOPHARM Oncology to Present at the 8th Annual BIO Investor Forum --. Oct 22, 2009 848
New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn's Archexin[TM] as Potent Inhibitor of Human Cancer Cell Growth. Oct 22, 2009 573
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin[R]. Oct 22, 2009 907
Cancer drug may provide treatment for chronic connective tissue disease. Oct 21, 2009 417
Chemo cocktail blocks breast cancer spread. Oct 21, 2009 234
Endocyte Presents Data on EC145 in Treatment of Ovarian Cancer Before the European Society of Gynaecologic Oncology. Oct 21, 2009 566
Endocyte Officials Announce Close of $26 Million Equity Financing. Oct 16, 2009 631
Ipsen and Debiopharm Group Announce That Decapeptyl[R] (triptorelin embonate) 6-Month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer. Oct 13, 2009 1247
Ireland : EirGen to sell new breast cancer drug. Oct 12, 2009 464
European Patent Office to Issue Patent to Phyton Biotech Covering Methods of Making Taxanes -- Compounds Useful in Cancer Treatment. Oct 12, 2009 370
Pre-targeting approach may lead to personalised cancer therapies. Oct 12, 2009 358
Chemo cocktail blocks breast cancer spread. Oct 12, 2009 232
Dr. Arno Mundt. Brief article Oct 12, 2009 277
United States: Ipsen and Spirogen enter into new agreement for development of SJG-136. Oct 9, 2009 291
Ipsen and Spirogen Redesign Their Collaboration for the Development of SJG-136 (Now SG2000). Oct 8, 2009 1291
SAVI Breast Cancer Therapy Featured on "The Doctors" TV Show. Oct 6, 2009 430
Research and Markets: Forecast Insight: Top 20 Cancer Therapy Brands - Targeted Therapies Will Drive Market Growth in the Wake of the Cytotoxic and Antihormonal Patent Cliff. Oct 5, 2009 390
Green tea could block benefits of cancer drug. Oct 5, 2009 318
Pre-targeting approach may lead to personalised cancer therapies. Oct 5, 2009 358
WYETH'S TORISEL APPROVED BY EUROPEAN COMMISSION. Oct 1, 2009 568
ENDOCYTE GETS MILESTONE PAYMENT FROM BRISTOL-METERS SQUIBB. Oct 1, 2009 307
Seattle Cancer Care Alliance, ProCure to Develop Proton Therapy Center. Sep 29, 2009 811
Scientists offer 'baby hope' for women on toxic cancer drugs. Sep 28, 2009 352
Schaeffer's Options Update: Allos Therapeutics' Pending FDA Approval Draws Heavy Put Volume. Sep 23, 2009 193
Cetuximab drug with chemo may cut death risk in lung cancer patients. Sep 22, 2009 310
Drug developer tests pancreatic cancer treatment: Abraxis cites progress in treating disease that killed Patrick Swayze. Crowe, Deborah Sep 21, 2009 371
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE[R] (bortezomib) for Injection. Sep 18, 2009 1474
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance. Sep 17, 2009 1152
U.S. Patent and Trademark Office Issues a Notice of Allowance in OSI Pharmaceuticals' Reissue Application on Tarceva[R] Composition of Matter Patent. Sep 17, 2009 835
SuperGen to Present at Upcoming Investment Conferences. Conference news Sep 16, 2009 193
Metabolomics Used to Identify the Mechanism of Action of an Anti-Cancer Drug. Sep 16, 2009 277
FDA and EMEA Grant Orphan Drug Designation for Antisense Pharma's Investigational Drug Trabedersen in Pancreatic Carcinoma. Sep 14, 2009 1343
Research and Markets: Prostate Cancer Therapy Area Pipeline Report: Status of Prostate Cancer Drugs by Company and by Stage and Summary of the Latest News and Developments. Report Sep 11, 2009 352
Research and Markets: Ovarian Cancer Therapy Area Pipeline Report. Report Sep 11, 2009 352
Research and Markets: Non-Hodgkin Lymphoma Therapy Area Pipeline Report. Report Sep 9, 2009 348
Cancer drug hopes to be dashed. Sep 9, 2009 194
Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation of the Ipsen's Proprietary CDC-251 Inhibitor (IRC-083864 or Debio 0931) an Anti-Cancer Agent. Sep 7, 2009 1126
Molecular signature may tell which cancer patients will respond to therapy. Sep 7, 2009 591
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo. Sep 5, 2009 199
India : Process Cipla's licence for 'Soranib': HC. Sep 5, 2009 266
United States : FDA OKs Spectrum s Zevalin as blood-cancer treatment. Sep 5, 2009 249
United States : FDA Approves Ibritumomab Tiuxetanton as First-Line Therapy for Non-Hodgkin's Lymphoma. Sep 5, 2009 161
United States : Biogen Idec offers $356.1M for Facet Biotech. Sep 5, 2009 298
United States : Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin s Lymphoma. Sep 5, 2009 290
SuperGen to Present at September Investment Conferences. Conference news Sep 3, 2009 198
New discovery may help in developing effective cancer therapies. Sep 3, 2009 328
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE[R] (bortezomib) For Injection. Sep 2, 2009 1561
Complete Guide to Complementary & Alternative Cancer Therapies, second edition. Book review Sep 1, 2009 99
Clinical trial: a company-sponsored clinical study by Amgen Inc. found that its anemia drug Aranesp didn't improve heart conditions of patients with chronic kidney disease, but didn't hurt the patients either. Clinical report Aug 31, 2009 94
India: DRL seeks USFDA help to make cancer drug clone. Aug 31, 2009 515
United States : Trubion licenses drug to Facet in $196.5M deal. Aug 29, 2009 225
United States: Facet Biotech invests in Trubion. Aug 29, 2009 273
Reportlinker Adds Chinese Markets for Lymphoma Treatment Drugs. Aug 27, 2009 129
Research and Markets: Competitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio Planning. Aug 27, 2009 393
Endocyte Says Collaboration Paying Off. Aug 26, 2009 307
Reportlinker Adds Molecular Targeted Cancer Therapies Market Forecast. Aug 25, 2009 179
Research and Markets: Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report - Drug Status by Company and by Stage as Well as a Summary of the Latest News and Developments. Report Aug 25, 2009 350
Breakthrough discovery may help develop breast cancer drug within 2yrs. Aug 25, 2009 565
China : Simcere Announces Strategic Partnership with Sun Yat-Sen University Cancer Center. Aug 24, 2009 300
United States : Clinical Data licenses cancer drug for $252M. Aug 14, 2009 155
Clinical Data, Inc. Announces Collaboration with CombinatoRx for the Development of Novel B-Cell Cancer Therapy. Aug 13, 2009 812
Research and Markets: Commercial Insight: the Antihormonals Market Was Worth $6.9 Billion in 2008 across the Seven Major Pharmaceutical Markets. Aug 13, 2009 405
United States : Clinical Data, Inc. Announces Collaboration with CombinatoRx for the Development of Novel B-Cell Cancer Therapy. Clinical report Aug 13, 2009 278
Research and Markets: A Comprehensive and Detailed Report on Colorectal Cancer or Colon Cancer Therapy Area Pipeline. Report Aug 12, 2009 363
Research and Markets: Head and Neck Cancer Therapy Area Pipeline Report - Detailed Information on the Head and Neck Cancer Drug Pipeline. Report Aug 12, 2009 360
Research and Markets: Breast Cancer Therapy Area Pipeline Report: Extensive Details on Drug Pipelines by Company and Stage and Latest Company News. Report Aug 12, 2009 352
United States : OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011. Aug 10, 2009 255
How Much Should Cancer Drugs Cost? Landmark Cornell University Study Sheds New Light on Old Assumptions. Aug 4, 2009 588
SuperGen's MP-470 Demonstrates Clinical Benefit in Small Cell Lung Cancer and Neuroendocrine Tumor Patients. Aug 3, 2009 627
Generate antiangiogenic peptides by the action of B. polymyxa protease. Aug 1, 2009 478
Science park tenant arrives. Geiger, Daniel Jul 29, 2009 656
Cancer drugs could help alcoholics. Brief article Jul 1, 2009 213
Psychological issues that may affect breast cancer trial recruitment. Graham, Helen Report Jun 1, 2009 1856
Isis offers hope. Brief article May 1, 2009 210
mTOR as a validated cancer target. Brief article May 1, 2009 191
RESprotect Elucidates The Mode Of Action Of Its Anti-Cancer Drug RP101: Binding To Heat Shock Protein Hsp27. Mar 31, 2009 501
Biotech company creates uproar with petition to require FDA oversight of lab-developed tests. McCarty, Michael N. Mar 1, 2009 371
Efficacy of cisplatin and vinorelbine in patients with metastatic non-small cell lung carcinoma/ Metastatik kucuk hucreli disi akciger karsinomlu hastalarda sisplatin ve vinorelbinin etkinligi. Yilmaz, Ufuk; Halilcolar, Huseyin; Yildirim, Yasemin; Yapicioglu, Sena; Unsal, Ipek; Mahlec, Ceyda Clinical report Dec 1, 2008 2750

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles